InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by dEsparbes Eric, Chief Financial Officer. Officer active across 3 companies, notably PROGENITY, INC.. Aggregated, 16 filings have been published. History available since 15 August 2021. The latest transaction was disclosed on 15 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
27,830 shares@ US$0.6710.8% of flowCommon StockSEC:0000950170-24-098046:0
325,000 shares0Common StockSEC:0000950170-24-015862:0
40,022 shares@ US$3.1473.5% of flowCommon StockSEC:0000950170-23-043225:0
2,807 shares@ US$3.355.5% of flowCommon StockSEC:0000950170-23-022773:0
62,225 shares0Common StockSEC:0000899243-23-009032:0
269 shares@ US$3.460.6% of flowCommon StockSEC:0000899243-23-005465:0
95 sharesSeries X Preferred StockSEC:0000899243-23-000958:0
5,194 shares@ US$0.270.9% of flowCommon StockSEC:0000899243-22-036077:0
5,952 shares@ US$1.043.9% of flowCommon StockSEC:0000899243-22-028839:0
10,387 shares@ US$0.750.0000% mcap100.0% of flowCommon StockSEC:0000899243-22-018428:0
231,693 shares0Common StockSEC:0000899243-22-015063:0
4,919 shares@ US$1.9025.3% of flowCommon StockSEC:0000899243-22-006785:0
4,919 shares@ US$1.9050.7% of flowCommon StockSEC:0000899243-22-006785
5,718 shares@ US$1.6624.7% of flowCommon StockSEC:0000899243-21-033252:0
5,718 shares@ US$1.6624.7% of flowCommon StockSEC:0000899243-21-033252
115,734 sharesCommon StockSEC:0001179110-16-017813:0
16 of 16 declarations
About dEsparbes Eric
Eric d'Esparbes is the Chief Financial Officer of Progenity, Inc. and Biora Therapeutics, Inc., companies specializing in health solutions. In this role, he oversees the financial management of both companies, including financial planning and analysis. With extensive experience in finance, he plays a key role in financial strategy and growth for the companies.
